Latest Corporate News News
GSK Enters Agreement to Acquire RAPT Therapeutics
GSK plc announced a definitive agreement to acquire RAPT Therapeutics for $58.00 per share in cash via tender offer, expected to close in Q1 2026. The deal is subject to customary conditions including Hart-Scott-Rodino approval and majority shareholder tender. GSK will account for it as a business combination.
Calavo Growers to be Acquired by Mission Produce
Calavo Growers (NASDAQ: CVGW) agreed to a cash-and-stock merger with Mission Produce (NASDAQ: AVO) at $27.00 per share ($14.85 cash + 0.9790 Mission shares), valuing Calavo at $430 million enterprise value. Both boards approved; closure expected by August 2026 pending conditions. Cozen O'Connor represented Calavo.
D-Wave Quantum Completes Acquisition of Quantum Circuits
D-Wave Quantum (QBTS) finalized its acquisition of all equity in Quantum Circuits, Inc. on January 20, 2026, per the January 6 merger agreement. The transaction involved subsidiaries Quest Acquisition Merger Sub I and II. Details filed with SEC.
Sydor Optics Acquires Vertex Optics for Expansion
Sydor Optics acquired Vertex Optics, its first acquisition, to boost precision optics capabilities ahead of a new 100,000 sq ft facility in Rochester by summer 2027. Both brands continue; serves aerospace, defense, and more. Workforce integrates 20 from Vertex.